Intracranial EEG power and metabolism in human epilepsy.
EEG power and high frequency activity in the seizure onset zone has been increasingly considered for its relationship with seizures in animal and human studies of epilepsy. We examine the relationship between quantitative EEG measures and metabolic imaging in epilepsy patients undergoing intracranial EEG (icEEG) analysis for seizure localization. Patients with mesial temporal lobe epilepsy (MTLE) and neocortical epilepsy (NE) were studied. Metabolic imaging was performed with MR spectroscopic imaging using N-acetyl aspartate (NAA) and creatine (Cr). All data were acquired from the mesial temporal lobe such that a direct comparison of the same anatomical regions between the two groups could be performed. While no difference was seen in the total power recorded from the mesial temporal lobe, the MTLE group had significantly greater power in the high frequency bands. There was a significant positive exponential relationship between total icEEG power with NAA/Cr in MTLE, R=+0.84 and p<0.001, which was not seen in NE. There was also a significant negative relationship between fractional gamma power with NAA/Cr in MTLE, R=-0.66 and p<0.02, also not seen in NE. These data argue that within the seizure onset zone, the tight correlation between total power and NAA/Cr suggests that total electrical output is powered by available mitochondrial function. These data are also consistent with the hypothesis that high frequency activity is an abnormal manifestation of tissue injury.
Pan
J W
JW
Department of Neurosurgery, Yale University School of Medicine, New Haven, CT 06520, USA. jullie.pan@yale.edu
Zaveri
H P
HP
Spencer
D D
DD
Hetherington
H P
HP
Spencer
S S
SS
D000293:Adolescent; D000328:Adult; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D001921:Brain / Q000378:metabolism* / Q000503:physiopathology; D003401:Creatine / Q000378:metabolism; D004567:Electrodes, Implanted; D004569:Electroencephalography; D004734:Energy Metabolism; D004827:Epilepsy / Q000378:metabolism* / Q000503:physiopathology; D005260:Female; D005583:Fourier Analysis; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008875:Middle Aged; D012640:Seizures / Q000378:metabolism* / Q000503:physiopathology
D001224:Aspartic Acid; C000179:N-acetylaspartate; D003401:Creatine
Hum Brain Mapp. 2009 Apr;30(4):1226-35
18609565
Neurology. 2005 Jan 25;64(2):282-9
15668426
Brain. 2008 Jul;131(Pt 7):1818-30
18556663
Epilepsia. 2008 Nov;49(11):1881-92
18479398
Neurology. 2002 Aug 27;59(4):633-6
12196667
Epilepsia. 2002 Oct;43(10):1197-209
12366736
Epilepsia. 2001 Jun;42(6):725-30
11422326
Clin Neurophysiol. 2006 Sep;117(9):2102-8
16887380
Brain. 2007 Sep;130(Pt 9):2354-66
17626037
Brain. 2008 Apr;131(Pt 4):928-37
18263625
J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1240-4
12933926
Appl Neuropsychol. 2001;8(3):155-60
11686650
Epilepsia. 1998 Jan;39(1):67-76
9578015
Neurology. 2007 Dec 11;69(24):2256-65
18071146
Epilepsia. 2008 Jan;49(1):40-50
17822430
Brain. 2007 Feb;130(Pt 2):314-33
17008335
Neuroreport. 1996 May 31;7(8):1397-400
8856684
Neurochem Res. 1995 Jan;20(1):31-8
7739756
Epilepsy Res. 2008 Sep;81(1):58-68
18547787
Epilepsia. 2007 Nov;48(11):2130-8
17662059
Ann Neurol. 2005 Jan;57(1):92-7
15546136
Clin Neurophysiol. 2005 Mar;116(3):532-44
15721067
Epilepsia. 2001 Nov;42(11):1403-7
11879342
J Neurosci. 2002 Mar 1;22(5):2012-21
11880532